- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2008–2023 · research · R01
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment
Sapna Syngal · Dana-Farber Cancer Institute · funded by National Institutes of Health
2008–2023 · research · R01
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment
Sapna Syngal · Dana-Farber Cancer Institute · funded by National Institutes of Health
2008–2022 · research · R01
Thermogenic chromatin remodeling control and fat tissue communication
Pere Puigserver · Dana-Farber Cancer Institute · funded by National Institutes of Health
2008–2027 · research · R01
Metabolic crosstalks in regulation of beta-cell stress response and adaptation
Nika N Danial · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2020 · research · R01
Dietary And Lifestyle Determinants Of Colon Cancer Recurrence and Survival
Charles S Fuchs · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2025 · program · P50
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
Nabeel El-Bardeesy · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2020 · research · R01
Preprocessing and Analysis Tools for High-Throughput Technologies
Rafael Angel Irizarry · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2024 · program · P50
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
Nabeel El-Bardeesy · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2021 · research · R01
Dual role of BAD in insulin secretion and beta cell survival
Nika N Danial · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2020 · research · R01
Preprocessing and Analysis Tools for High-Throughput Technologies
Rafael Angel Irizarry · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2020 · research · R01
Preprocessing and Analysis Tools for High-Throughput Technologies
Rafael Angel Irizarry · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2024 · program · P50
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
Adam Joel Bass · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2024 · program · P50
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
Nabeel El-Bardeesy · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2024 · program · P50
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
Nabeel El-Bardeesy · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2023 · research · R01
Dual role of BAD in insulin secretion and beta cell survival
Nika N Danial · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2024 · program · P50
Project 4 - Characterizing and Overcoming Resistance to ERBB2 Directed Therapy in Metastatic Gastric and Esophageal Adenocarcinoma
Sandra Ryeom · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2025 · program · P50
Developmental Project Program
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2025 · program · P50
Core B - Pathology and Biospecimen Core
Sicinska · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2025 · program · P50
Project 3 - Improving Therapy for DNA-Damage Deficient Pancreatic Adenocarcinoma
Brian Matthew Wolpin · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2024 · program · P50
Career Enhancement Program
Robert J Mayer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2024 · program · P50
Core A - Administrative Core
Adam Joel Bass · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2024 · program · P50
Project 2 - Exploiting FGF Receptor Signaling Dependence in Liver Cancer Therapy
Nabeel El-Bardeesy · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2025 · program · P50
Project 4 - Characterizing and Overcoming Resistance to ERBB2 Directed Therapy in Metastatic Gastric and Esophageal Adenocarcinoma
Adam Joel Bass · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2025 · program · P50
Project 1 - Integrating targeted and immune therapies for BRAF mutant colorectal cancer
Ryan Bruce Corcoran · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2025 · program · P50
Core A - Administrative Core
Adam Joel Bass · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2024 · program · P50
Core B - Pathology and Biospecimen Core
Sicinska · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2024 · program · P50
Developmental Project Program
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2025 · program · P50
Career Enhancement Program
Robert J Mayer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2024 · program · P50
Core C - Bioinformatics and Biostatistics Core
John Quackenbush · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2024 · program · P50
Project 3 - Improving Therapy for DNA-Damage Deficient Pancreatic Adenocarcinoma
Brian Matthew Wolpin · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2025 · program · P50
Core C - Bioinformatics and Biostatistics Core
John Quackenbush · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2025 · program · P50
Project 2 - Exploiting FGF Receptor Signaling Dependence in Liver Cancer Therapy
Nabeel El-Bardeesy · Dana-Farber Cancer Institute · funded by National Institutes of Health
2007–2024 · program · P50
Project 1 - Integrating targeted and immune therapies for BRAF mutant colorectal cancer
Ryan Bruce Corcoran · Dana-Farber Cancer Institute · funded by National Institutes of Health
2006–2022 · research · R01
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
Michael J Eck · Dana-Farber Cancer Institute · funded by National Institutes of Health
2006–2022 · research · R01
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
Michael J Eck · Dana-Farber Cancer Institute · funded by National Institutes of Health
2006–2023 · research · R01
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
Michael J Eck · Dana-Farber Cancer Institute · funded by National Institutes of Health
2006–2026 · cooperative agreement · U24
Bioconductor: An Open-Source, Open-Development Computing Resource for Genomics
Vincent James Carey · Dana-Farber Cancer Institute · funded by National Institutes of Health
2006–2023 · research · R01
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
Michael J Eck · Dana-Farber Cancer Institute · funded by National Institutes of Health
2006–2026 · cooperative agreement · U24
Bioconductor: An Open-Source, Open-Development Computing Resource for Genomics
Vincent James Carey · Dana-Farber Cancer Institute · funded by National Institutes of Health
2006–2021 · research · R01
Integrase Structural Virology
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
